$380.93
0.78% yesterday
NYSE, Jun 11, 10:10 pm CET
ISIN
US0367521038
Symbol
ELV

Elevance Health Stock price

$380.93
-35.76 8.58% 1M
-4.63 1.20% 6M
+12.03 3.26% YTD
-156.00 29.05% 1Y
+116.39 44.00% 5Y
+216.96 132.32% 10Y
+312.43 456.10% 20Y
NYSE, Closing price Wed, Jun 11 2025
-2.99 0.78%
ISIN
US0367521038
Symbol
ELV
Sector

Key metrics

Market capitalization $86.07b
Enterprise Value $116.07b
P/E (TTM) P/E ratio 14.63
EV/FCF (TTM) EV/FCF 32.17
EV/Sales (TTM) EV/Sales 0.63
P/S ratio (TTM) P/S ratio 0.47
P/B ratio (TTM) P/B ratio 2.02
Dividend yield 1.71%
Last dividend (FY24) $6.52
Revenue growth (TTM) Revenue growth 6.63%
Revenue (TTM) Revenue $183.12b
EBIT (operating result TTM) EBIT $9.03b
Free Cash Flow (TTM) Free Cash Flow $3.61b
EPS (TTM) EPS $26.04
P/E forward 11.95
P/S forward 0.44
EV/Sales forward 0.59
Short interest 1.15%
Show more

Is Elevance Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.

Elevance Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Elevance Health forecast:

18x Buy
75%
6x Hold
25%

Analyst Opinions

24 Analysts have issued a Elevance Health forecast:

Buy
75%
Hold
25%

Financial data from Elevance Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
183,124 183,124
7% 7%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses - -
-
-
- Research and Development Expense - -
-
-
9,645 9,645
2% 2%
5%
- Depreciation and Amortization 619 619
19% 19%
0%
EBIT (Operating Income) EBIT 9,026 9,026
1% 1%
5%
Net Profit 5,917 5,917
5% 5%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Elevance Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Elevance Health Stock News

Neutral
PRNewsWire
about 9 hours ago
NEW YORK , June 11, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the "Class Period"), of the important July 11, 2025 lead plaintiff deadline. So what: If you purchased Elevance Health common stock during the Class Period you m...
Neutral
PRNewsWire
about 15 hours ago
BENSALEM, Pa. , June 11, 2025 /PRNewswire/ -- The Law Offices of Howard G.
Neutral
PRNewsWire
2 days ago
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Elevance To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Elevance between April 18, 2024 and October 16, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330  ...
More Elevance Health News

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Head office United States
CEO Gail Boudreaux
Employees 104,200
Founded 1944
Website www.elevancehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today